Consistent with this, intranasal delivery of IL‐1β or mucosal delivery of IL‐1β‐encoding adenoviral vectors along with influenza vaccine boosts immune responses against influenza infections, demonstrating that its immune‐stimulatory effect is physiologically important [5, 6]. The gene discussed is IL1B; the disease is influenza.